-
Guided design for the development of an evolution-proof influenza vaccine
Myburgh, L., van Loon, K., Huijbers, E. J. M., van Beijnum, J. R., Russell, C. A. & Griffioen, A. W., 20 Jun 2025, In: Vaccine. 59, 127281.Research output: Contribution to journal › Review article* › Academic › peer-review
-
Targeting the early life stages of SARS-CoV-2 using a multi-peptide conjugate vaccine
Myburgh, L., Karsjens, H., Blanas, A., de Ligt, A., van Loon, K., Huijbers, E. J. M., van Beijnum, J. R., Engbersen, D. J. M., Rekiki, A., Mignon, C., Vratskikh, O. & Griffioen, A. W., 30 Apr 2025, In: Vaccine. 54, 126989.Research output: Contribution to journal › Article* › Academic › peer-review
-
Embryonic reprogramming of the tumor vasculature reveals targets for cancer therapy
Huijbers, E. J. M., van Beijnum, J. R., van Loon, K., Griffioen, C. J., Volckmann, R., Bassez, A., Lambrechts, D., Monteiro, M. N., Jimenez, C. R., Hogendoorn, P. C. W., Koster, J. & Griffioen, A. W., 25 Mar 2025, In: Proceedings of the National Academy of Sciences of the United States of America. 122, 12, e2424730122.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
